Cunesoft GmbH, a cloud software provider for regulatory document and submission management, specialized in the pharmaceutical industry, announced hat it successfully closed an investment round with High-Tech Gründerfonds and Bayern Kapital. The funds will be used to further internationalize sales activities as well as to expand the software's capabilities.

Within the pharmaceutical industry, the filing of the drug submission dossier involves critical and regulated processes. As the first European-based provider of a SaaS (Software as a Service) model Cunesoft now provides an integrated online regulatory software solution for effective submission document preparation as well as eCTD (electronic Common Technical Document) drug submission publishing.

"We are excited about having won High-Tech Gründerfonds and Bayern Kapital as investors", say Daniel Koppers and Rainer Schwarz. "The funding will allow us to include important collaborative features into the software. For example, a direct connection of the Cunesoft online platform with authority submission portals will be completed. Another area of functional expansion is the secure collaboration and sharing of our customers documents and dossiers with their external suppliers and customers."